If you have mantle cell lymphoma or multiple myeloma, your healthcare provider may recommend chemotherapy treatment with Velcade® (bortezomib). It is approved for use in adults only, and comes as an injection that is administered by your healthcare provider. It can be given as a slow injection into a vein (intravenous, or IV, injection) or just beneath the skin (subcutaneously).
Your dosage of Velcade is individualized based on your height and weight, how well you tolerate it, and whether you are taking certain other drugs or supplements. Possible side effects include nausea, diarrhea, and weakness.
(Click Velcade for more details on what to expect during treatment, including how the drug works, when and how it is given, and why it is not safe for use in some people.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Velcade Web site. Available at: http://www.velcade.com. Accessed March 20, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. FDA approved drug products. FDA Web site. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed March 20, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed March 20, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click